# As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period

> **NCT04215848** · PHASE3 · COMPLETED · sponsor: **Hat Yai Medical Education Center** · enrollment: 31 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/Formoterol Fumarate 160 MCG-4.5 MCG Inhalation Powder
- **DRUG:** Budesonide 200Mcg Inhalation Powder

## Key facts

- **NCT ID:** NCT04215848
- **Lead sponsor:** Hat Yai Medical Education Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-10-10
- **Final completion:** 2022-05-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04215848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04215848, "As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04215848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*